Verdijk P, et al. First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Stratton P, et al. Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant: a nonrandomized clinical trial.
Porras C, et al. Efficacy of the bivalent HPV vaccine against HPV16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Leeman A, et al. Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions.